Primobolan (Metenolone)

Mild DHT derivative. Injectable (enanthate) or oral (acetate, 17α-alkylated). Considered one of the safest AAS.

Overview

AASDHT Derivative

Mild DHT derivative. Injectable (enanthate) or oral (acetate, 17α-alkylated). Considered one of the safest AAS.

Effects on Markers

Mild lipid impact (less than most AAS), minimal liver stress (injectable), does not aromatize, moderate HPTA suppression. Oral form is 17-alpha alkylated with mild liver stress.

Compound Guide

Ester: Enanthate (injectable, 7-carbon chain) or Acetate (oral, 17-alpha alkylated).

Dosage:

  • Injectable (Enanthate): 400-800 mg/week for 12-20 weeks
  • Oral (Acetate): 50-100 mg/day for 6-8 weeks (less common, mild liver stress)

Injection Protocol:

  • Injectable: 2x/week IM, 25g needle, glutes/VG/delts
  • Oral: split dose 2x/day

Key Notes:

  • Considered the mildest injectable AAS -- minimal side effects at moderate doses
  • Does not aromatise -- no E2 increase, no water retention
  • Mild but consistent lean gains; popular for "lean bulk" or recomp
  • Relatively gentle on lipids compared to other AAS (but still worsens HDL)
  • Requires higher doses than most AAS for noticeable effects (400mg+ weekly)
  • Often expensive due to high demand and frequent counterfeiting
  • Good option for users prioritising health alongside enhancement

Usage History

Markers to Monitor

Frequently Asked Questions

Quick Reference

Category

AAS

Half-Life

5-7 days (injectable) / 4-6 hours (oral)

Detection Time

5 months

Usage Summary